Well Characterized Biologicals

IBC's Well Characterized Biologicals conference is the leading industry conference to provide multiple, detailed case studies of the challenges, strategies and technologies involved in characterizing new biological molecules. You'll have the opportunity to learn about the CMC strategies for many different types of biological products, and interact directly with FDA regulators who will share best practices and expectations for well-characterized products. No other conference on the market provides more case studies and unpublished new data that you can only hear about by attending this event. Find strategies for legacy products, new complex molecules, vaccines, combination products, biosimilars, ADC's, bispecifics and other recombinant proteins.

New This Year! 2nd Conference Track Added to IBC's Well Characterized Biologicals event:

Drug Product Formulation and Delivery

Complementing the current emphasis on analytical strategies for Drug Substance, this new, concurrent track will feature Drug Product strategies and technologies for complex formulations, delivery systems and devices, so you can cross-fertilize ideas with attendees from different disciplines... analytical development, process development and formulation development... for better characterized biologicals!